Who owns ALXO?
Institutional ownership of ALX Oncology Holdings Inc. from Form 13F, Q2 2026
94 institutional managers reported holding ALX Oncology Holdings Inc. (ALXO) in Form 13F filings for Q2 2026, with 105,938,046 shares worth $219M. The largest reported holder was Ra Capital Management, L.p. Managers that filed both quarters added a net 11,669,126 shares (+12.4%). 37 opened new positions and 11 sold out.
- Funds holding
- 94
- Value held
- $219M
- New / sold out
- 37 / 11
- Net shares, same filers
- +12.4%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ALXO
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Ra Capital Management, L.p. | $26.9M | 12.3% | 13,011,849 | Unchanged |
| venBio Partners LLC | $26.7M | 12.2% | 12,884,638 | Unchanged |
| BlackRock, Inc. | $15.3M | 7.0% | 7,399,530 | Added |
| Redmile Group, LLC | $15.3M | 7.0% | 7,392,504 | Trimmed |
| Blackstone Inc. | $13.6M | 6.2% | 6,593,543 | Added |
| Driehaus Capital Management LLC | $12.5M | 5.7% | 6,025,240 | Added |
| Silverarc Capital Management, LLC | $11.9M | 5.4% | 5,744,757 | New |
| TCG Crossover Management, LLC | $11.7M | 5.3% | 5,655,487 | Trimmed |
| Vanguard Capital Management LLC | $10.3M | 4.7% | 4,973,436 | Added |
| Vivo Capital, LLC | $6.6M | 3.0% | 3,184,713 | Unchanged |
| Marshall Wace, LLP | $6.4M | 2.9% | 3,071,496 | Trimmed |
| 5AM Venture Management, LLC | $6.3M | 2.9% | 3,057,325 | Unchanged |
| Almitas Capital LLC | $6.1M | 2.8% | 2,938,431 | Trimmed |
| Orbimed Advisors LLC | $5.9M | 2.7% | 2,866,256 | Unchanged |
| Geode Capital Management, LLC | $5.8M | 2.6% | 2,787,809 | Added |
| Two Sigma Investments, LP | $4.5M | 2.1% | 2,178,176 | Added |
| Millennium Management LLC | $3.2M | 1.5% | 1,543,594 | Trimmed |
| Nantahala Capital Management, LLC | $3.1M | 1.4% | 1,500,000 | New |
| State Street Corp | $3.1M | 1.4% | 1,498,905 | Added |
| Acadian Asset Management LLC | $2.7M | 1.2% | 1,313,490 | Added |
| JPMorgan Chase & Co | $2.3M | 1.0% | 1,044,728 | Added |
| Northern Trust Corp | $1.9M | 0.9% | 935,669 | Added |
| Ensign Peak Advisors, Inc | $1.7M | 0.8% | 810,297 | Trimmed |
| Vanguard Portfolio Management LLC | $1.6M | 0.7% | 749,229 | Added |
| Vanguard Fiduciary Trust Co | $1.5M | 0.7% | 743,491 | Added |
Share of 13F holdings is each fund's shares as a share of the 105,938,046 ALXO shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$14.4M
- Silverarc Capital Management, LLC New+$11.9M
- Geode Capital Management, LLC Added+$4.7M
- Nantahala Capital Management, LLC New+$3.1M
- State Street Corp Added+$2.7M
- JPMorgan Chase & Co Added+$2.3M
- Northern Trust Corp Added+$1.7M
- Vanguard Capital Management LLC Added+$1.6M
- Blackstone Inc. Added+$1.6M
- Vanguard Portfolio Management LLC Added+$1.3M
Biggest sellers in Q2 2026
- TCG Crossover Management, LLC Trimmed-$15.2M
- Adage Capital Partners GP, L.l.c. Sold out-$4.0M
- Squadron Capital Management LLC Sold out-$2.9M
- Susquehanna International Group, LLP Trimmed-$2.5M
- Marshall Wace, LLP Trimmed-$1.4M
- Redmile Group, LLC Trimmed-$1.2M
- Bank of America Corp Trimmed-$1.0M
- UBS Group AG Trimmed-$935K
- Millennium Management LLC Trimmed-$921K
- Almitas Capital LLC Trimmed-$487K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $56.8M and sold $32.3M; 28 added and 10 trimmed.
Schedule 13D and 13G filings on ALXO
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-19Coastlands Capital LP SCHEDULE 13G filed by ALX Oncology Holdings Inc.Schedule 13G
- 2026-07-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-02-09RA CAPITAL MANAGEMENT, L.P. SCHEDULE 13G filed by ALX Oncology Holdings Inc.Schedule 13G
- 2025-10-08MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by ALX Oncology Holdings Inc.Schedule 13G
Questions about ALXO ownership
- Who owns ALXO stock?
- 94 institutional investment managers reported ALXO positions in their Form 13F filings for Q2 2026, holding 105,938,046 shares worth $219M in total. Ra Capital Management, L.p. reported the largest position.
- Are funds buying or selling ALXO?
- In Q2 2026, 37 managers opened new ALXO positions, 28 added, 10 trimmed and 11 sold out. Managers that filed in both quarters added a net 11,669,126 shares.
- How current is this ALXO institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ALXO by CUSIP. Options are left out. ALXO news and filings · ALXO insider trades · Top funds